Adapt Pharma touted data today from 2 human factors studies that evaluated the usability of its Narcan nasal spray by adolescents and people with low literacy.
The Dublin-based company’s product is a ready-to-use, needle-free device that delivers a single dose of naloxone in a nasal spray to someone experiencing an opioid overdose and does not require assembly prior to use, according to Adapt Pharma.
Get the full story at our sister site, Drug Delivery Business News.
The post Adapt Pharma touts usability data for Narcan nasal spray appeared first on MassDevice.